Responses
Poster Presentations
Psoriatic arthritis
THU0427 Sustained Improvements in Skin Outcomes Following Certolizumab Pegol Treatment of Psoriatic Arthritis Patients with Prior Anti-TNF Exposure or Severe Skin Involvement at Baseline
Compose a Response to This Article
Other responses
No responses have been published for this article.